New treatment of free-radical scavenger in adrenoleukodystrophy

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 3, 2011, Pages 412-415

  Kawashima, H ^a   Nishimata, S ^a   Ishii, C ^a   Yamanaka, G ^a   Kashiwagi, Y ^a   Takekuma, K ^a   Hoshika, A ^a   Watanabe, Y ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

adrenoleukodystrophy; d ROM; edaravone; free radical scavenger; nitrite nitrate; short latency somatosensory evoked potential

Indexed keywords

NORPHENAZONE; SCAVENGER;

ADRENOLEUKODYSTROPHY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; HUMAN; MALE; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHOOL CHILD; SOMATOSENSORY SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADRENOLEUKODYSTROPHY; ANTIPYRINE; CHILD; EVOKED POTENTIALS, SOMATOSENSORY; FREE RADICAL SCAVENGERS; HUMANS; MALE; NEURONS; REACTIVE OXYGEN SPECIES; SYNAPTIC TRANSMISSION; UPPER EXTREMITY;

EID: 79955778522     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01267.x     Document Type: Article

References (9)

1. Peters C, Charnas LR, Tan Y, et al. (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood, 104, 881-888. (Pubitemid 38970588)
2. Vargas CR, Wajner M, Sirtori LR, et al. (2004) Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochimica et Biophysica Acta, 1688, 26-32. (Pubitemid 38366303)
3. Kawashima H, Amaha M, Ioi H, et al. (2005) Nitrite/nitrate (NOx) and zinc concentrations in influenza-associated encephalopathy in children with different sequela. Neurochemical Research, 30, 311-314. (Pubitemid 40880806)
4. Yamanaka G, Kawashima H, Suganami Y, et al. (2006) Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. Journal of the Neurological Sciences, 243, 71-75.
5. Nakamura M, Yamanaka G, Kawashima H, et al. (2005) Clinical application of rapid assay of interleukin-6 in influenza-associated encephalopathy. Disease Markers, 21, 199-202. (Pubitemid 43074403)
6. Iinuma K, Haginoya K, Handa I, et al. (1989) Computed tomography, magnetic resonance imaging, positron emission tomography and evoked potentials at early stage of adrenoleukodystrophy. Tohoku Journal of Experimental Medicine, 159, 195-203. (Pubitemid 20184916)
7. Tsujita K, Shimomura H, Kaikita K, (2006) Long-term efficacy of edaravone in patients with acute myocardial infarction. Circulation Journal, 70, 832-837. (Pubitemid 43979118)
8. Arii K, Kumon Y, Ikeda Y, Suehiro T, Hashimoto K, (2006) Edaravone inhibits the disease activity in rheumatoid arthritis. Journal of Clinical Pharmacy and Therapeutics, 31, 197-199.
9. Noor JI, Ikeda T, Ueda Y, Ikenoue T, (2005) A free radical scavenger, edaravone, inhibits lipid peroxidation and the production of nitric oxide in hypoxic-ischemic brain damage of neonatal rats. American Journal of Obstetrics and Gynecology, 193, 1703-1708. (Pubitemid 41540470)